Inventor · Boulder, CO, US

Julia Haas

64Patents
16h-index
67Co-inventors
83Inventor score

Filing activity: Dec 15, 2004 → Jun 27, 2023

Most-cited inventions

PatentTitleAreaCited byStatus
US8933084B2 Macrocyclic compounds as Trk kinase inhibitors Emerging Cross-Sectional Technologies 80 Active
US8513263B2 Substituted pyrazolo[1,5-a]pyrimidine compounds as Trk kinase inhibitors Emerging Cross-Sectional Technologies 77 Active
US8791123B2 Substituted pyrazolo[1,5-a]pyrimidine compounds as Trk kinase inhibitors Emerging Cross-Sectional Technologies 68 Active
US8450322B2 Substituted imidazo[1,2b]pyridazine compounds as Trk kinase inhibitors Emerging Cross-Sectional Technologies 66 Active
US8119592B2 Compounds and methods for inhibiting hepatitis C viral replication Chemistry; Metallurgy 50 Active
US8865698B2 Method of treatment using substituted pyrazolo[1,5-a]pyrimidine compounds Emerging Cross-Sectional Technologies 43 Active
US9493476B2 Macrocyclic compounds as trk kinase inhibitors Emerging Cross-Sectional Technologies 43 Active
US9127013B2 Method of treatment using substituted pyrazolo[1,5-a] pyrimidine compounds Emerging Cross-Sectional Technologies 40 Active
US9682979B2 Substituted pyrazolo [1,5-A] pyrimidine compounds as TRK kinase inhibitors Emerging Cross-Sectional Technologies 25 Active
US9902741B2 Macrocyclic compounds as TRK kinase inhibitors Emerging Cross-Sectional Technologies 22 Active
US9718822B2 Macrocyclic compounds as Trk kinase inhibitors Emerging Cross-Sectional Technologies 22 Active
US9676783B2 Method of treatment using substituted pyrazolo[1,5-A] pyrimidine compounds Emerging Cross-Sectional Technologies 22 Active
US9750744B2 Macrocyclic compounds as Trk kinase inhibitors Emerging Cross-Sectional Technologies 21 Active
US9840519B2 Macrocyclic compounds as TRK kinase inhibitors Emerging Cross-Sectional Technologies 21 Active
US9447104B2 Method of treatment using substituted pyrazolo[1,5-a]pyrimidine compounds Emerging Cross-Sectional Technologies 20 Active
US9782415B2 Substituted pyrazolo[1,5-a]pyrimidine compounds as Trk kinase inhibitors Emerging Cross-Sectional Technologies 19 Active
US9796724B2 Substituted pyrazolo[1,5-a]pyrimidine compounds as Trk kinase inhibitors Emerging Cross-Sectional Technologies 16 Active
US9796723B2 Method of treatment using substituted imidazo[1,2b]pyridazine compounds Emerging Cross-Sectional Technologies 15 Active
US9795611B2 Method of treatment using substituted imidazo[1,2b]pyridazine compounds Emerging Cross-Sectional Technologies 15 Active
US10112942B2 Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors Chemistry; Metallurgy 14 Active
US9227975B2 Method of treatment using substituted imidazo[1,2B]pyridazine compounds Emerging Cross-Sectional Technologies 12 Active
US10174027B2 Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors Chemistry; Metallurgy 12 Active
US10138243B2 Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors Chemistry; Metallurgy 10 Active
US10174028B2 Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors Chemistry; Metallurgy 10 Active
US10005783B2 Method of treatment using substituted pyrazolo[1,5-a] pyrimidine compounds Emerging Cross-Sectional Technologies 9 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.